Cancer stem cells targeted therapy: A changing concept in head and neck squamous cell carcinoma

Adesh S Manchanda1, Harmandeep K Rai2, Manvir Kaur2

  • 1Department of Oral and Maxillofacial Pathology, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab, India.

Insights

Cancer stem cells (CSCs) drive cancer initiation and relapse, prompting targeted therapies. This review explores CSCs in head and neck squamous cell carcinoma (HNSCC), focusing on identification and SC-targeted treatments.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Head and Neck Cancer Research

Background:

  • Cancer stem cells (CSCs) possess self-renewal and multilineage potential, revolutionizing cancer treatment concepts.
  • CSCs are implicated in cancer initiation, progression, relapse, and resistance to conventional therapies.
  • Understanding stem cell (SC) properties and localization in cancer enables targeted therapeutic strategies.

Purpose of the Study:

  • To review the role of CSCs in the development and relapse of head and neck squamous cell carcinoma (HNSCC).
  • To discuss surface markers for CSC identification in HNSCC.
  • To explore SC-targeted therapy options for HNSCC, including advantages, challenges, and future research directions.

Main Methods:

  • Literature review focusing on CSCs in HNSCC.
  • Analysis of studies identifying CSC surface markers.
  • Evaluation of current and emerging SC-targeted therapeutic approaches for HNSCC.

Main Results:

  • CSCs play a significant role in HNSCC initiation, progression, and recurrence.
  • Specific surface markers aid in the identification and isolation of HNSCC CSCs.
  • SC-targeted therapies offer potential for improved HNSCC treatment outcomes, despite existing challenges.

Conclusions:

  • Targeting CSCs is a promising strategy for managing HNSCC and reducing patient mortality.
  • Further research into CSC biology and targeted therapies is crucial for advancing HNSCC treatment.
  • Addressing the challenges of SC-targeted therapy will be key to its successful clinical application in HNSCC.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K